Innovation Digest: The Lux Take on the Future of Digital Biomarkers

November 23, 2020 | State of the Market Report

Digital biomarkers are biomarkers based on non-invasive and continuous data collected via devices like wearables and smartphones, analyzed using advanced analytics to extract previously invisible insights. These biomarkers have been shown to be important in developing early diagnostics for mental health conditions, physiological disease, and viral pathogen outbreaks. Digital biomarkers are an increasingly critical underpinning to digital health tools such as digital therapeutics, and the remote monitoring and mHealth components of telehealth, and the broader trend of healthcare transitioning from being provider-centric to patient-centric. In this report, we will explore the readiness of digital biomarkers for entry to market, identifying opportunities in this space.

Coverage Areas

  • Digital Transformation
  • Emerging Ecosystems in Agrifood and Health

Table of Contents

  • Title page

Lead Analyst


About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978